Back to search

France· FR:69681469

LONSURF 15 mg/6,14 mg, comprimé pelliculé

A medicinal product containing trifluridine + chlorhydrate de tipiracil, registered in France by LES LABORATOIRES SERVIER, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLONSURF 15 mg/6,14 mg, comprimé pelli…ATC—REGISTER NO.FR:69681469PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TRIFLURIDINE + CHLORHYDRATE DE TIPIRACIL
Manufacturer
LES LABORATOIRES SERVIER
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930057773
    2 plaquette(s) thermoformée(s) aluminium de 10 comprimé(s)
    EUR 376.33
  • cip13
    3400930057797
    6 plaquette(s) thermoformée(s) aluminium de 10 comprimé(s)
    EUR 1.09

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trifluridine + chlorhydrate de tipiracil in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trifluridine + chlorhydrate de tipiracil products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Belgium · Trifluridine/Tipiracil Eugia
  • Spain · Trifluridina/Tipiracilo Eugia
  • Iceland · Lonsurf
  • Liechtenstein · Lonsurf
  • Luxembourg · Trifluridine/Tipiracil Eugia
  • Netherlands · Trifluridine, Tipiracil Eugia
  • Norway · Lonsurf
  • Portugal · Trifluridina + Tipiracilo Eugia

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c43fcd97-7f72-43ea-9fd8-3ac19a9d7b33
GET /v1/drugs/c43fcd97-7f72-43ea-9fd8-3ac19a9d7b33?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69681469",
  "date_amm": "2016-04-25",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/16/1096",
  "substance": "TRIFLURIDINE + CHLORHYDRATE DE TIPIRACIL",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about trifluridine + chlorhydrate de tipiracil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.